Comparative Pharmacology
Head-to-head clinical analysis: CYSTEINE HYDROCHLORIDE versus MUCOMYST W ISOPROTERENOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CYSTEINE HYDROCHLORIDE versus MUCOMYST W ISOPROTERENOL.
CYSTEINE HYDROCHLORIDE vs MUCOMYST W/ ISOPROTERENOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cysteine hydrochloride serves as a precursor to glutathione, an important antioxidant. It also provides a source of cysteine for protein synthesis and acts as a mucolytic agent by reducing disulfide bonds in mucus glycoproteins, thereby decreasing viscosity.
Acetylcysteine reduces mucous viscosity by cleaving disulfide bonds in mucoproteins, enhancing clearance of respiratory secretions. Isoproterenol is a non-selective beta-adrenergic agonist that stimulates beta-1 and beta-2 receptors, causing bronchodilation and increased mucociliary clearance.
Intravenous: 0.8-1 g/m²/day divided every 6 hours for acetaminophen poisoning; for parenteral nutrition, 0.66-1.7 g of cysteine/kg/day (as hydrochloride).
Acetylcysteine 10-20% solution 3-5 mL via nebulization with isoproterenol 0.5 mL (0.5 mg) q6-8h; isoproterenol dose adjusted to heart rate not exceeding 120/min.
None Documented
None Documented
Terminal elimination half-life: 1.5-3 hours in adults with normal renal function; prolonged in renal impairment (up to 8-10 hours in severe cases).
Acetylcysteine: terminal half-life is approximately 5.6 hours in adults (range 3-8 hours); increased in patients with hepatic impairment. Isoproterenol: half-life is approximately 2.5-5 minutes due to rapid hepatic and tissue metabolism.
Renal: 40-60% as unchanged drug and metabolites; fecal: <5%; minor biliary elimination; route of administration (e.g., intravenous) influences exact percentages.
Acetylcysteine and isoproterenol are both extensively metabolized. Acetylcysteine is metabolized in the liver to cysteine and other metabolites; renal excretion of inorganic sulfate and unchanged drug accounts for less than 30% of the dose. Isoproterenol is rapidly metabolized by COMT and other pathways; less than 2% is excreted unchanged in urine.
Category C
Category C
Mucolytic
Mucolytic/Bronchodilator Combination